Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.424
+0.037 (9.61%)
At close: Mar 9, 2026, 4:00 PM EDT
0.429
+0.005 (1.20%)
After-hours: Mar 9, 2026, 4:30 PM EDT
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $14.60 million as of March 9, 2026. Its market cap has decreased by -47.29% in one year.
Market Cap
14.60M
Enterprise Value
12.78M
1-Year Change
-47.29%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $14.60M, a decrease of -88.97%. That is a compound annual growth rate of -82.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 13.32M | -62.06% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hoth Therapeutics | 14.89M |
| Quoin Pharmaceuticals | 14.65M |
| Curis | 14.54M |
| Cocrystal Pharma | 14.06M |
| GT Biopharma | 13.84M |
| NewcelX | 13.58M |
| OSR Holdings | 13.56M |
| Quantum BioPharma | 13.38M |